Naturally Splendid (TSXV:NSP) will be presenting an expanded line of cannabidiol-formulated products at Foodex Japan 2017 from March 7 to March 10, in addition to the line of CBD-formulated capsules announced in a previous news release.
Naturally Splendid is pleased to announce its wholly owned U.S. subsidiary has signed an exclusive
Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company focused on the development of central nervous system therapies based on its neural stem cell technology, today announced that U.S. Patent No. 9572807 was issued by the United States Patent and Trademark Office (USPTO) for NSI-189, the lead compound in Neuralstem’s neurogenic small molecule
Align Technology, Inc. (NASDAQ: ALGN) today expanded workflow options for the iTero® intraoral scanner by announcing the availability of a digital workflow for Nobel Biocare implants. iTero customers can now order Nobel Biocare implant cases through their dental labs. Dental labs can now order NobelProcera® single-unit restorations for their doctors,
Naturally Splendid (TSXV:NSP) will be presenting at FOODEX Japan 2017 from March 7 to March 10. FOODEX Japan is the largest annual food and beverage trade show in Asia, and has been a highly successful trade event since its debut in 1976, serving Japan’s $585-billion food market and additional significant
Laguna Blends (CSE:LAG; OTCMKTS:LAGBF; FRA:LB6A) announces that it has signed an exclusive distribution agreement with Iso International, LLC. (“Isodiol). Isodiol is one of the world’s leading suppliers, formulators and manufacturers of pharmaceutical grade CBD products. Isodiol will provide its experience in research, development and manufacturing and offer all of its
Takeda Pharmaceutical Company Limited (TSE: 4502) (“Takeda”) and TiGenix NV (Euronext Brussels and Nasdaq: TIG) (“TiGenix”) today announced new data from the Phase 3 ADMIRE-CD clinical trial, which indicated that investigational compound Cx601, a suspension of allogeneic adipose-derived stem cells (eASC), maintained long-term remission of treatment refractory complex perianal fistulas
Medtronic plc (NYSE: MDT) today announced Japan regulatory approval for the world’s smallest pacemaker, the Micra(TM) Transcatheter Pacing System (TPS). Japan’s Pharmaceuticals and Medical Device Agency (PMDA) granted approval for Micra based on positive data from the Medtronic Micra TPS Global Clinical Trial, which enrolled 744 patients and evaluated the
Recent supply disruptions at key mines have the copper price flying high, but will they have a lasting impact?
The project is located in the Athabasca Basin and Cameco has the option to earn a 70-percent stake in it.
Medtronic plc (NYSE: MDT) announced the launch of its Signia(TM) Stapling System. The latest addition to the company’s MIS portfolio, the Signia system provides surgeons with real-time feedback and automated responses to that real-time data.The Signia system includes Adaptive Firing(TM) technology that measures the firing force and adjusts the stapler’s
By Emma Harwood
Wi2Wi Corporation (TSXV:YTY), announces that Mr. Daniel Phelan has resigned as a director and Chairman of the Board of Directors. Mr. Michael R. Sonnenreich and Fraser C. Henderson Sr., M.D have joined the Board of Directors and Mr. Sonnenreich was elected as the Chairman of the Board of Directors.
K2M Group Holdings, Inc. (NASDAQ:KTWO) (the “Company” or “K2M”), a global leader of complex spine and minimally invasive solutions focused on achieving three-dimensional Total Body BalanceTM, today introduced Balance ACSTM (or BACSTM), a comprehensive platform that applies three-dimensional solutions across the entire clinical care continuum to help drive quality outcomes for
Paladin Energy (ASX: PDN) (TSX: PDN) announces the release of its condensed consolidated interim financial report for the half-year reporting period ended 31 December 2016. The condensed consolidated financial report is appended to this News Release.
References below to 2016 and 2015 are to the equivalent six months ended 31 December 2016
A recent article in mining.com highlighted Graphite One Resources Inc. (TSXV:GPH, OTCQX:GPHOF) and the United States’ foreign reliance on key minerals and the growing need to begin production on domestic mines.
NuGene International, Inc. (“NuGene”) (OTCQB: NUGN), a developer, manufacturer, and marketer of advanced skin and hair care lines utilizing human adipose derived stem cell conditioned media, today announced that it has appointed John Ohanesian as Chief Strategic Advisor, Hair. This is a new position at NuGene and Mr. Ohanesian’s appointment
Zogenix, Inc. (NASDAQ:ZGNX), a pharmaceutical company developing therapies for the treatment of orphan and central nervous system (CNS) disorders, today announced the initiation of the clinical efficacy portion of Study 1504 for ZX008 in patients with Dravet syndrome. Study 1504 is a multi-center, two-cohort study to initially assess the pharmacokinetic